Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  1. Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis

    Publikation: Bidrag til tidsskriftKort undersøgelseForskningpeer review

  2. Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The prognostic impact of mild/moderate liver impairment among critically ill patients is not known. We aimed to determine whether acute liver impairment, as measured by several biomarkers, (i) is frequent, (ii) influences prognosis and (iii) to determine whether such an effect is specific for infected critically ill patients. A biomarker and clinical cohort study based on a randomized controlled trial. All-cause mortality was the primary endpoint. Biomarkers hyaluronic acid (HA), bilirubin, albumin, alkaline phosphatase and the international normalized ratio (INR) were determined. Multivariable statistics were applied to estimate risk increase according to liver biomarker increase at baseline and the model was adjusted for age, APACHE II, severe sepsis/septic shock vs. milder infection, chronic alcohol abuse Charlson's co-morbidity index, cancer disease, surgical or medical patient, body mass index, sex, estimated glomerular filtration rate, mechanical ventilation and the other biomarkers. Time-to-event graphs were used. The patients were critically ill patients (n = 1096) from nine mixed medical/surgical intensive care units without known hepatobiliary disease. HA levels differed between infected patients (median 210.8 ng/mL [IQR: 93.2-556.6]) vs. the non-infected (median 56.8 ng/mL [IQR: 31.9-116.8], p < 0.001). Serum HA quartiles 2, 3 and 4 were independent predictors of 90-day all-cause mortality for the entire population (infected and non-infected). However, the signal was driven by the infected patients (positive interaction test, no signal in non-infected patients). Among infected patients, HA quartiles corresponded directly to the 90-day risk of dying: 1st quartile: 57/192 = 29.7%, 2nd quartile: 84/194 = 43.3%, 3rd quartile: 90/193 = 46.6%, 4th quartile: 101/192 = 52.3 %, p for trend: <0.0001. This finding was confirmed in adjusted analyses: hazard ratio vs. 1st quartile: 2nd quartile: 1.3 [0.9-1.8], p = 0.14, 3rd quartile: 1.5 [1.1-2.2], p = 0.02, 4th quartile: 1.9 [1.3-2.6], p < 0.0001). High bilirubin was also an independent predictor of mortality. Among infected critically ill patients, subtle liver impairment, (elevated HA and bilirubin), was associated with a progressive and highly increased risk of death for the patient; this was robust to adjustment for other predictors of mortality. HA can identify patients at high risk.

TidsskriftClinical Chemistry and Laboratory Medicine
Udgave nummer9
Sider (fra-til)1422-1431
StatusUdgivet - 27 aug. 2019

ID: 56962127